The table below shows SOLENO THERAPEUTICS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$94.60M
$66.02M
$32.66M
-
-
-
Cost of revenue
$1.20M
$1.14M
$696.00K
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$11.27M
$8.40M
$9.15M
$13.52M
$30.14M
$12.34M
SG&A
SLNO annual revenue (10-K history)
SOLENO THERAPEUTICS INC reported annual revenue of $190.41M for fiscal year 2025. That is up 13024.2% from $1.45M in fiscal 2016. Over the 5 fiscal years shown, annual revenue grew from $3.00M (FY 2013) to $190.41M. Figures come from the company's audited annual reports as filed with the SEC.